DEWPOINT THERAPEUTICS
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.
DEWPOINT THERAPEUTICS
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.dewpointx.com
Total Employee:
101+
Status:
Active
Total Funding:
287 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Pound Sterling Japanese Yen MailChimp SPF
Similar Organizations
Aerovate Therapeutics
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Intergalactic Therapeutics
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Board_observer
2020-09-01
Board_member
2019-11-01
Board_member
2020-09-01
Board_member
Board_member
2018-11-01
Current Employees Featured
Richard Young Co-Founder @ Dewpoint Therapeutics
Co-Founder
Anthony Hyman Co Founder @ Dewpoint Therapeutics
Co Founder
Ameet Nathwani Chief Executive Officer @ Dewpoint Therapeutics
Chief Executive Officer
2020-10-01
Michael Fenn Director External Innovation @ Dewpoint Therapeutics
Director External Innovation
2020-01-01
Mark Murcko Founding CSO & Member of the Board of Directors @ Dewpoint Therapeutics
Founding CSO & Member of the Board of Directors
2018-11-01
Rebecca Zacks Vice President, Community and Content @ Dewpoint Therapeutics
Vice President, Community and Content
Lori (Burrell) Escobedo Chief People Officer @ Dewpoint Therapeutics
Chief People Officer
2021-09-01
Founder
Investors List
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Dewpoint Therapeutics
Mirae Asset Capital
Mirae Asset Capital investment in Series C - Dewpoint Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Dewpoint Therapeutics
General Catalyst
General Catalyst investment in Series C - Dewpoint Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Series C - Dewpoint Therapeutics
Maverick Ventures
Maverick Ventures investment in Series C - Dewpoint Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Dewpoint Therapeutics
NS Investment
NS Investment investment in Series C - Dewpoint Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - Dewpoint Therapeutics
3E Bioventures
3E Bioventures investment in Series C - Dewpoint Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-28 | Dewpoint Therapeutics Appoints Lori Escobedo as Chief People Officer |
Official Site Inspections
http://www.dewpointx.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.47 K
- Host name: 169.110.212.35.bc.googleusercontent.com
- IP address: 35.212.110.169
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Dewpoint Therapeutics"
About us | Dewpoint Therapeutics
The emerging science of biomolecular condensates completely transforms the understanding of cellular function and organization, solving some of biology’s greatest mysteries. Our Team We …See details»
Dewpoint Therapeutics - Crunchbase Company Profile …
Contact Email info@dewpointx.com Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its …See details»
Dewpoint Therapeutics - LinkedIn
Dewpoint Therapeutics | 13,094 followers on LinkedIn. Translating condensate biology into medicine. | Dewpoint is the first company to apply an emerging understanding of biomolecular condensates ...See details»
Dewpoint Therapeutics Welcomes Dr. Lis Leiderman as …
BOSTON, Massachusetts, June 24, 2024 – Dewpoint Therapeutics Inc., a biotechnology company that is translating the novel science of condensates into breakthrough therapeutics, today announced the appointment of Lis …See details»
Leaps by Bayer
Approach. Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by …See details»
Dewpoint Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Learn more at Dewpointx.com and follow us on X and LinkedIn. About Condensates Condensates are membraneless organelles that form dynamically throughout the cell via a process called …See details»
Dewpoint Therapeutics - VentureRadar
Website: https://dewpointx.com. Applies emerging understanding of biomolecular condensates to drug discovery, with over 20 development programs across oncology, neuromuscular, …See details»
Dewpoint Therapeutics - Overview, News & Similar companies
Aug 17, 2022 www.dewpointx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Dewpoint Therapeutics partners with Novo …See details»
About DEWPOINT THERAPEUTICS | DxMultiomics
_↗ dewpointx.com. Oct 28, 2024. Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program _↗ dewpointx.com. Oct 24, 2024. Dewpoint Therapeutics Awarded …See details»
Dewpoint Therapeutics - workinbiotech.com
Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Condensates are important for cells to coordinate and control …See details»
Dewpoint Therapeutics and ConcertAI Announce the First Phase of …
Dec 12, 2024 Through collaborations with Bayer, Novo Nordisk, Evotec, and Mitsubishi Tanabe Pharma Corporation, Dewpoint pushes the boundaries to accelerate the translation of …See details»
The 5 candles of Dewpoint’s culture | Dewpoint Therapeutics
Oct 19, 2023 To support this spirit throughout the organization we have promised every member of the Dewpoint team: A unique opportunity to be a part of a revolution in medicine working …See details»
Dewpoint Therapeutics Awarded Target ALS Grant for the Second …
Aug 26, 2024 This in-kind grant is a collaboration with Biospective contract research organization. Today, there are no disease-modifying therapeutic options for the ~ 20,000 …See details»
How Does Dewpoint Therapeutics Work? – …
Oct 2, 2024 Website: dewpointx.com; Focus: Developing a drug platform that targets biomolecular condensates; Through their innovative approach, Dewpoint Therapeutics is …See details»
Dewpoint Therapeutics, Inc. (Dewpoint Therapeutics, Inc.) - 药物管 …
了解Dewpoint Therapeutics, Inc. (Dewpoint Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的48篇新闻和4篇文献，疾病领域:肿瘤，内分泌与代谢疾病，神经系统疾病，技 …See details»
Dewpoint Therapeutics Awarded Target ALS Grant for the
Aug 26, 2024 Learn more at Dewpointx.com and follow us on X and LinkedIn. ABOUT TARGET ALS Target ALS is a 501(c)(3) medical research foundation committed to the search for …See details»
Dewpoint Therapeutics Announces Completion of $150 Million …
BOSTON , February 3, 2022 – Dewpoint Therapeutics Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing.. The funding …See details»
Dewpoint Therapeutics announces upcoming presentations at
2 days ago Learn more at Dewpointx.com and follow us on LinkedIn. About Condensates Condensates are membraneless organelles that form dynamically throughout the cell via a …See details»
Bayer and Dewpoint Therapeutics sign Licensing Agreement for …
Oct 24, 2024 Learn more at Dewpointx.com. About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, …See details»
Dewpoint Therapeutics Awarded Target ALS Grant for the
Aug 26, 2024 This in-kind grant is a collaboration with Biospective contract research organization. Today, there are no disease-modifying therapeutic options for the ~ 20,000 …See details»